肺癌靶向治疗-话题@MedSci

#肺癌靶向治疗#

12篇内容 | 710人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1632501, encodeId=208e16325012b, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=韩宝惠：2020年肺癌靶向治疗进展年终盘点, objectType=article, longId=204261, objectId=b1c6204261db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1c6204261db, replyNumber=0, likeNumber=50, createdTime=2021-09-21, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1c6204261db, moduleTitle=韩宝惠：2020年肺癌靶向治疗进展年终盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1c6204261db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632499, encodeId=9b5b16324991b, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=肺癌靶向治疗耐药 “柳暗花明”, objectType=article, longId=192602, objectId=379f192602f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379f192602f5, replyNumber=0, likeNumber=41, createdTime=2020-06-17, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379f192602f5, moduleTitle=肺癌靶向治疗耐药 “柳暗花明”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=379f192602f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632500, encodeId=5c761632500f2, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=肺癌靶向治疗的现状和发展趋势 —— 精细、联合、克服耐药和脑转移, objectType=article, longId=193835, objectId=c7e6193835ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7e6193835ea, replyNumber=0, likeNumber=31, createdTime=2021-03-25, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7e6193835ea, moduleTitle=肺癌靶向治疗的现状和发展趋势 —— 精细、联合、克服耐药和脑转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7e6193835ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632498, encodeId=1c101632498d3, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=韩宝惠：“盘”根究底，“肺”比寻常——2019年肺癌靶向治疗年度进展盘点, objectType=article, longId=185730, objectId=b1a4185e3087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1a4185e3087, replyNumber=0, likeNumber=37, createdTime=2020-09-05, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1a4185e3087, moduleTitle=韩宝惠：“盘”根究底，“肺”比寻常——2019年肺癌靶向治疗年度进展盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1a4185e3087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632496, encodeId=eb6f1632496be, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=非小细胞肺癌靶向治疗进展, objectType=article, longId=178938, objectId=292c1e8938fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=292c1e8938fd, replyNumber=0, likeNumber=36, createdTime=2020-05-28, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=292c1e8938fd, moduleTitle=非小细胞肺癌靶向治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=292c1e8938fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632497, encodeId=b08f163249ec8, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=肺癌靶向治疗的现状和发展趋势——精细、联合、克服耐药和脑转移, objectType=article, longId=181037, objectId=7b7518103e06, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b7518103e06, replyNumber=0, likeNumber=46, createdTime=2020-03-18, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b7518103e06, moduleTitle=肺癌靶向治疗的现状和发展趋势——精细、联合、克服耐药和脑转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b7518103e06)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632494, encodeId=a637163249406, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=【激荡20年】肺癌靶向治疗研究进展里程碑（上）, objectType=article, longId=130121, objectId=ae2413012186, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae2413012186, replyNumber=0, likeNumber=39, createdTime=2018-05-18, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae2413012186, moduleTitle=【激荡20年】肺癌靶向治疗研究进展里程碑（上）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae2413012186)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632495, encodeId=4f90163249566, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=【激荡20年】肺癌靶向治疗研究进展里程碑（下）, objectType=article, longId=130226, objectId=03f913022641, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03f913022641, replyNumber=0, likeNumber=41, createdTime=2018-03-30, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03f913022641, moduleTitle=【激荡20年】肺癌靶向治疗研究进展里程碑（下）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03f913022641)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632492, encodeId=bf9d1632492c3, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=Oncotarget:强磁场科学中心在小细胞肺癌靶向治疗研究中取得进展, objectType=article, longId=106114, objectId=e6ea10611461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6ea10611461, replyNumber=0, likeNumber=47, createdTime=2017-07-29, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6ea10611461, moduleTitle=Oncotarget:强磁场科学中心在小细胞肺癌靶向治疗研究中取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6ea10611461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632493, encodeId=79481632493a4, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=王长利教授畅谈非小细胞肺癌靶向治疗领域热点问题, objectType=article, longId=127901, objectId=8cf712e90131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cf712e90131, replyNumber=0, likeNumber=36, createdTime=2019-01-03, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cf712e90131, moduleTitle=王长利教授畅谈非小细胞肺癌靶向治疗领域热点问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cf712e90131)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632491, encodeId=ba951632491aa, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=【一文读懂】肺癌靶向治疗一、二、三代药有什么区别？怎么选？, objectType=article, longId=94230, objectId=6f2594230f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f2594230f9, replyNumber=0, likeNumber=41, createdTime=2017-08-15, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f2594230f9, moduleTitle=【一文读懂】肺癌靶向治疗一、二、三代药有什么区别？怎么选？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f2594230f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632490, encodeId=40b216324907d, content=<a href='/topic/show?id=9b0b82250c7' target=_blank style='color:#2F92EE;'>#肺癌靶向治疗#</a>, objectTitle=JCO：预测非小细胞肺癌靶向治疗效果检测EGFR突变丰度很重要, objectType=article, longId=27163, objectId=bfc42e163b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfc42e163b7, replyNumber=0, likeNumber=34, createdTime=2014-08-01, rootId=0, userName=360611847, userId=b33f21916424, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfc42e163b7, moduleTitle=JCO：预测非小细胞肺癌靶向治疗效果检测EGFR突变丰度很重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfc42e163b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺癌靶向治疗

2020-05-29

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

韩宝惠：2020年肺癌靶向治疗进展年终盘点

2021-09-21

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

肺癌靶向治疗耐药 “柳暗花明”

2020-06-17

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

肺癌靶向治疗的现状和发展趋势 —— 精细、联合、克服耐药和脑转移

2021-03-25

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

韩宝惠：“盘”根究底，“肺”比寻常——2019年肺癌靶向治疗年度进展盘点

2020-09-05

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

非小细胞肺癌靶向治疗进展

2020-05-28

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

肺癌靶向治疗的现状和发展趋势——精细、联合、克服耐药和脑转移

2020-03-18

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

【激荡20年】肺癌靶向治疗研究进展里程碑（上）

2018-05-18

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

【激荡20年】肺癌靶向治疗研究进展里程碑（下）

2018-03-30

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

Oncotarget:强磁场科学中心在小细胞肺癌靶向治疗研究中取得进展

2017-07-29

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

王长利教授畅谈非小细胞肺癌靶向治疗领域热点问题

2019-01-03

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

【一文读懂】肺癌靶向治疗一、二、三代药有什么区别？怎么选？

2017-08-15

360611847 (审核中...)

前往app查看评论内容

#肺癌靶向治疗#

JCO：预测非小细胞肺癌靶向治疗效果检测EGFR突变丰度很重要

2014-08-01

科室
- - 订阅+
  - 更多科室
工具
服务